Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | |
|---|---|---|---|---|---|---|---|
| Operating cash flow (direct method) | |||||||
| Cash income from operating activities | 14.42%22.98M | 2.77%20.08M | 7.44%19.54M | 23.63%18.19M | 73.32%14.71M | 6.00%8.49M | 8.01M |
| Revenue from customers | 13.97%22.86M | 2.77%20.06M | 7.54%19.52M | 24.86%18.15M | 71.23%14.53M | 5.86%8.49M | --8.02M |
| Income from government grants | 1,236.52%328.78K | 0.00%24.6K | -37.75%24.6K | -77.69%39.52K | --177.14K | ---- | ---- |
| Other cash income from operating activities | ---211.42K | ---- | ---- | ---- | ---- | ---- | ---11K |
| Cash paid | 1.95%-22.74M | 0.80%-23.19M | -3.46%-23.38M | -11.26%-22.6M | -16.92%-20.31M | -18.27%-17.37M | -14.69M |
| Payments to suppliers for goods and services | 1.95%-22.74M | 0.80%-23.19M | -3.46%-23.38M | -11.26%-22.6M | -16.92%-20.31M | -18.27%-17.37M | ---14.69M |
| Direct interest paid | ---11.34K | ---- | ---- | ---- | ---- | ---- | ---- |
| Direct interest received | --35.23K | ---- | ---- | ---- | ---- | ---- | ---- |
| Operating cash flow | 108.27%257.49K | 18.98%-3.11M | 12.96%-3.84M | 21.21%-4.41M | 36.95%-5.6M | -32.97%-8.89M | ---6.68M |
| Investing cash flow | |||||||
| Cash flow from continuing investing activities | -13,604.69%-1.88M | 82.36%-13.75K | 50.16%-77.92K | -63.10%-156.34K | -88.78%-95.85K | -20.89%-50.78K | -42K |
| Net PPE purchase and sale | -46.79%-73.98K | 48.18%-50.4K | 16.33%-97.25K | -38.35%-116.22K | 5.35%-84.01K | 14.66%-88.75K | ---104K |
| Net intangibles purchas and sale | 10.28%-5.92K | 41.15%-6.6K | 75.54%-11.21K | -78.45%-45.82K | -71.85%-25.68K | 81.32%-14.94K | ---80K |
| Net business purchase and sale | ---1.8M | ---- | ---- | ---- | ---- | ---- | ---- |
| Interest received (cash flow from investment activities) | ---- | 41.62%43.25K | 435.96%30.54K | -58.79%5.7K | -73.87%13.83K | -65.64%52.92K | --154K |
| Net other investing changes | ---- | ---- | ---- | ---- | ---- | ---- | ---12K |
| Cash from discontinued investing activities | |||||||
| Investing cash flow | -13,604.69%-1.88M | 82.36%-13.75K | 50.16%-77.92K | -63.10%-156.34K | -88.78%-95.85K | -20.89%-50.78K | ---42K |
| Financing cash flow | |||||||
| Cash flow from continuing financing activities | 959.46%2.67M | -106.66%-311.04K | 1,332.44%4.67M | -103.05%-378.92K | 34.48%12.43M | 1,062.96%9.24M | -960K |
| Net common stock issuance | --2.99M | ---- | --5.02M | ---- | 33.68%12.8M | 1,097.80%9.58M | ---960K |
| Interest paid (cash flow from financing activities) | 26.50%-42.5K | 26.45%-57.82K | -50.10%-78.62K | -22.69%-52.38K | -5.76%-42.69K | ---40.37K | ---- |
| Net other financing activities | 45.44%-276.32K | 6.56%-506.45K | 17.01%-542K | 1.19%-653.1K | -12.39%-660.96K | ---588.11K | ---- |
| Cash from discontinued financing activities | |||||||
| Financing cash flow | 959.46%2.67M | -106.66%-311.04K | 1,332.44%4.67M | -103.05%-378.92K | 34.48%12.43M | 1,062.96%9.24M | ---960K |
| Net cash flow | |||||||
| Beginning cash position | -53.91%3M | 13.11%6.52M | -46.14%5.76M | 167.76%10.7M | 8.19%4M | -67.54%3.69M | --11.38M |
| Current changes in cash | 130.45%1.05M | -558.75%-3.44M | 115.14%749.46K | -173.53%-4.95M | 2,098.30%6.73M | 103.98%306.26K | ---7.69M |
| Effect of exchange rate changes | 58.87%-31.22K | -1,375.35%-75.9K | -53.14%5.95K | 144.31%12.7K | -633.74%-28.66K | ---3.91K | ---- |
| End cash Position | 33.81%4.02M | -53.91%3M | 13.11%6.52M | -46.14%5.76M | 167.76%10.7M | 8.18%4M | --3.69M |
| Free cash from | 105.60%177.6K | 19.76%-3.17M | 13.67%-3.95M | 19.89%-4.58M | 36.46%-5.71M | -30.91%-8.99M | ---6.87M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |